Cytori Therapeutics, Inc. (CYTX) Reports In-Line Q1 Loss of 16c/Share
Get Alerts CYTX Hot Sheet
Join SI Premium – FREE
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $1.48 million, versus $1.36 million reported last year.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Volcon (VLCN) Reports 2023 Operational and Financial Results
- Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!